Limits of Patentability Plant Sciences, Stem Cells and Nucleic Acids

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section...

Full description

Bibliographic Details
Main Authors: Hübel, Andreas, Storz, Ulrich (Author), Hüttermann, Aloys (Author)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 2013, 2013
Edition:1st ed. 2013
Series:SpringerBriefs in Biotech Patents
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 02508nmm a2200445 u 4500
001 EB000390174
003 EBX01000000000000000243227
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9783642328411 
100 1 |a Hübel, Andreas 
245 0 0 |a Limits of Patentability  |h Elektronische Ressource  |b Plant Sciences, Stem Cells and Nucleic Acids  |c by Andreas Hübel, Ulrich Storz, Aloys Hüttermann 
250 |a 1st ed. 2013 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 2013, 2013 
300 |a VIII, 46 p. 2 illus  |b online resource 
505 0 |a Preface -- Andreas Hübel: The Boundaries of Limits - Plant Biosciences -- Ulrich Storz: The Limits of Patentability - Stem Cells -- Aloys Hüttermann: The LImits of Patentability - Genes and Nucleic Acids -- About the Authors 
653 |a Commercial law 
653 |a Plant biotechnology 
653 |a Chemical Bioengineering 
653 |a Plant Biotechnology 
653 |a Medical Genetics 
653 |a Stem cells 
653 |a Medical genetics 
653 |a Stem Cell Biology 
653 |a Biotechnology 
653 |a Commercial Law 
653 |a Biomaterials 
653 |a Nucleic Acid 
653 |a Nucleic acids 
700 1 |a Storz, Ulrich  |e [author] 
700 1 |a Hüttermann, Aloys  |e [author] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a SpringerBriefs in Biotech Patents 
028 5 0 |a 10.1007/978-3-642-32841-1 
856 4 0 |u https://doi.org/10.1007/978-3-642-32841-1?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 571.6 
082 0 |a 616.02774 
520 |a SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer’s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids